These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6791474)

  • 1. Vascular permeability factor produced by lymphocytes of patients with nephrotic syndrome.
    Sobel A; Heslan JM; Branellec A; Lagrue G
    Adv Nephrol Necker Hosp; 1981; 10():315-32. PubMed ID: 6791474
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokine 'skin reactive factor' (SRF) and the nephrotic syndrome.
    Lagrue G; Branellec A; Xheneumont S; Weil B
    Bibl Anat; 1975; 13():331-4. PubMed ID: 1231773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.
    Lagrue G; Xheneumont S; Branellec A; Hirbec G; Weil B
    Biomedicine; 1975 Feb; 23(1):37-40. PubMed ID: 1174637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor of capillary permeability in lymphocyte culture supernatant in nephrotic syndromes. Preliminary results].
    Lagrue G; Xhenemont S; Branellec A
    Nouv Presse Med; 1973 Jun; 2(25):1719. PubMed ID: 4718546
    [No Abstract]   [Full Text] [Related]  

  • 5. [The glomerular permeability factor].
    Birmelé B; Girardin E; Nivet H
    Nephrologie; 2001; 22(3):99-103. PubMed ID: 11436670
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.
    Sobel AT; Branellec AI; Blanc CJ; Lagrue GA
    J Immunol; 1977 Oct; 119(4):1230-4. PubMed ID: 894032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular permeability factor in the supernatant of lymphocyte cultures in subjects with nephrotic syndrome].
    Lagrue G; Branellec A; Xheneumont S; Hanbec G; Weil B
    J Urol Nephrol (Paris); 1975; 81(4-5):344-8. PubMed ID: 1099228
    [No Abstract]   [Full Text] [Related]  

  • 8. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties.
    Lagrue G; Branellec A; Blanc C; Xheneumont S; Beaudoux F; Sobel A; Weil B
    Biomedicine; 1975 Feb; 23(2):73-5. PubMed ID: 168931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular permeability factor and nephrotic syndrome.
    Trompeter RS; Barratt TM; Layward L
    Lancet; 1978 Oct; 2(8095):900. PubMed ID: 81452
    [No Abstract]   [Full Text] [Related]  

  • 10. [Structure and functions of the kidney glomerulus. Permeability to macromolecular substances in the kidney glomerulus].
    Honda N
    Nihon Rinsho; 1988 Jun; 46(6):1201-5. PubMed ID: 2458495
    [No Abstract]   [Full Text] [Related]  

  • 11. The glomerular capillary and disease.
    Michael AF; Nevins T; Fish A; Scheinman J
    Aust N Z J Med; 1981; 11(Suppl 1):76-82. PubMed ID: 7020670
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of a lymphokine acting upon vascular permeability. Initial application in renal pathology].
    Lagrue G; Sobel A; Branellec A; Blanc C
    Ann Med Interne (Paris); 1978 Jan; 129(1):57-60. PubMed ID: 637461
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular permeability increasing factor (VPF) in IgA nephropathy.
    Bakker WW; Beukhof JR; van Luijk WH; van der Hem GK
    Clin Nephrol; 1982 Oct; 18(4):165-7. PubMed ID: 7140031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.
    Doucet A; Favre G; Deschênes G
    Pediatr Nephrol; 2007 Dec; 22(12):1983-90. PubMed ID: 17554565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast media in vascular radiology. Presentation of a new product].
    Dana M; Bourdeau J; Touati M; Delaveau G; Desprez-Curely JP
    J Radiol Electrol Med Nucl; 1970; 51(8):512-6. PubMed ID: 5488492
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome.
    van den Berg JG; Weening JJ
    Clin Sci (Lond); 2004 Aug; 107(2):125-36. PubMed ID: 15157184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New findings on the pathogenesis of nephrotic syndrome (review article)].
    Tesar V; Zima T; Kalousová M
    Sb Lek; 2002; 103(3):379-95. PubMed ID: 12688182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1).
    Kaukinen A; Kuusniemi AM; Lautenschlager I; Jalanko H
    Nephrol Dial Transplant; 2008 Apr; 23(4):1224-32. PubMed ID: 18048423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Lymphokines and nephrotic syndrome.
    Lagrue G; Xheneumont S; Branellec A; Weil B
    Lancet; 1975 Feb; 1(7901):271-2. PubMed ID: 46408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.